| Metric | შპს SmartPharm | შპს ფარმაცევტული სახლი + |
|---|---|---|
| Growth | ||
| Revenue | ₾31.6m₾33.9m | ₾61.6m₾65.5m |
| Revenue growth | -6.8% | -5.8% |
| Profitability | ||
| EBITDA | ₾3.3m₾4.0m | -₾11.7m-₾2.7m |
| EBITDA margin | 10.4%11.7% | -18.9%-4.1% |
| Net profit | ₾2.8m₾4.1m | -₾11.2m-₾3.1m |
| Net margin | 8.8%12.1% | -18.2%-4.8% |
| Balance sheet | ||
| Total assets | ₾13.4m₾15.1m | ₾66.5m₾48.9m |
| Total equity | ₾11.6m₾11.0m | -₾17.3m-₾6.0m |
| ROE | 23.9%37.0% | — |